Compound for treating and relieving neurodegenerative disease

Abstract

The invention discloses a compound for treating and relieving neurodegenerative diseases and relates to the technical field of medicine. The compound is an artemisinin derivative, and the artemisinin derivative comprises artemether, arteether, artesunatum, dihydroartemisinin and pharmaceutically acceptable minor ingredients. The compound for treating and relieving neurodegenerative diseases can treat presenile dementia, Parkinson syndrome and Huntington's diseases, the toxic and side effect is low, the cost is low, no drug resistance is produced, the compound can be taken for a long term and the practicability is strong.

Description

Technical field: [0001] The invention relates to a compound for treating and alleviating neurodegenerative diseases, belonging to the technical field of medicine. Background technique: [0002] With the aging of the world's population, the incidence of neurodegenerative diseases such as Alzheimer's disease (AD) is on the rise, and it has become the most common dementia among the elderly, second only to cardiovascular and cerebrovascular diseases. After cancer, it is another disease that seriously threatens the health of the elderly. The etiology and pathogenesis of neurodegenerative diseases have not been fully clarified, there is a lack of ideal animal models that fully simulate the characteristics of neurodegenerative diseases such as AD, and there is a lack of effective drugs for the treatment of neurodegenerative diseases such as AD. To study the etiology and pathogenesis of AD and other neurodegenerative diseases, to develop effective drugs for the treatment of AD and ...

AI Technical Summary

Problems solved by technology

[0005] At present, rapamycin is the main intervention drug commonly used in clinical practice, but

Images